Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.490
+0.020 (1.36%)
At close: Feb 27, 2026

Duopharma Biotech Berhad Ratios and Metrics

Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,4331,2021,2121,5331,5822,386
Market Cap Growth
20.16%-0.79%-20.94%-3.10%-33.70%145.56%
Enterprise Value
1,6351,4691,5221,8191,8812,521
Last Close Price
1.491.221.201.501.552.28
PE Ratio
16.3919.1923.0221.8724.0940.72
Forward PE
14.6614.7414.7715.9120.9734.68
PS Ratio
1.541.481.722.202.484.19
PB Ratio
1.891.701.762.342.543.71
P/TBV Ratio
1.991.711.782.352.563.73
P/FCF Ratio
17.9020.1276.43301.61-156.62
P/OCF Ratio
13.4214.4324.8421.8236.6233.45
PEG Ratio
0.740.7212.311.104.113.40
EV/Sales Ratio
1.761.812.162.612.944.42
EV/EBITDA Ratio
9.1110.7013.3514.8016.3623.80
EV/EBIT Ratio
12.2214.6619.3419.5721.1930.79
EV/FCF Ratio
20.4224.5995.99357.77-165.43
Debt / Equity Ratio
0.660.730.800.660.650.47
Debt / EBITDA Ratio
2.963.664.673.413.412.77
Debt / FCF Ratio
6.168.6334.6184.91-19.91
Net Debt / Equity Ratio
0.300.350.410.420.430.23
Net Debt / EBITDA Ratio
1.381.832.442.232.311.37
Net Debt / FCF Ratio
2.814.2017.5553.90-4.029.54
Asset Turnover
0.640.600.550.580.570.58
Inventory Turnover
2.172.081.831.822.062.28
Quick Ratio
1.622.652.591.131.181.95
Current Ratio
2.544.084.062.052.153.06
Return on Equity (ROE)
11.59%8.97%7.84%10.96%10.36%9.99%
Return on Assets (ROA)
5.62%4.60%3.83%4.87%4.99%5.17%
Return on Invested Capital (ROIC)
10.08%8.15%6.91%8.44%8.37%8.61%
Return on Capital Employed (ROCE)
11.10%8.40%6.70%9.70%9.50%9.00%
Earnings Yield
6.10%5.21%4.34%4.57%4.15%2.46%
FCF Yield
5.59%4.97%1.31%0.33%-4.18%0.64%
Dividend Yield
2.01%2.47%1.92%1.53%1.41%2.14%
Payout Ratio
38.49%42.99%16.81%11.70%68.45%12.34%
Buyback Yield / Dilution
0.12%-0.36%-1.08%-2.15%-0.02%-3.86%
Total Shareholder Return
2.16%2.11%0.85%-0.62%1.39%-1.72%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.